Back to Press Releases

Clarify Health Solutions Raises $57 Million in Series B Financing Round Led by KKR

September 10, 2018

Investment will fuel company’s growth in building the industry’s first real-time care guidance platform

SAN FRANCISCO & NEW YORK–(BUSINESS WIRE)– Clarify Health Solutions, Inc. (“Clarify” or the “Company”), a pioneer in real-time care guidance technology, today announced that it has closed $57 million in a Series B financing round led by KKR, a global investment firm. Building upon the Company’s rapid customer expansion in 2018, the injection of new capital will fuel the Company’s growth on its mission to power the personalization and optimization of every care journey.

Clarify brings hospital, health insurance, and life sciences customers the latest financial services and consumer technologies coupled with the deep clinical expertise needed to power innovative care delivery models. Clarify’s solutions deploy predictive analytics and machine learning on a comprehensive data set of over 20 terabytes – representing clinical, claims, social determinant, laboratory, and prescription data – to provide actionable insights and automate care navigation. The Company’s Care Journey Platform enables doctors to gain the confidence of matching patients to the most appropriate care, while patients benefit from real-time visibility and guidance.

Clarify plans to use the new funding to expand its clinical transformation, sales, engineering, and data science teams, to acquire new data assets, and to accelerate the development of its digital care guidance platform. This will help widen Clarify’s reach in supporting customers in their delivery of more effective and delightful care to patients nationwide.

“We are thrilled to partner with KKR to build the world’s first real-time care guidance platform,” said Jean Drouin, MD, CEO and Co-Founder, Clarify Health Solutions. “We are entering a new era, where technology can help us to reimagine care delivery. We have accepted for far too long that an accessible, service-oriented, and customer-centric experience is simply unattainable in health care. We are committed to making the words ‘delightful,’ ‘healed,’ and ‘affordable’ far more common in the health care lexicon.”

For KKR, the investment is being funded through the firm’s Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies for which KKR can be a unique partner in helping reach scale.

“Today’s health care market is not only very complicated but also extremely fragmented and marked by patient dissatisfaction,” said Ali Satvat, Member of KKR and Head of KKR’s Health Care Strategic Growth investing efforts. “The impressive and highly experienced team at Clarify is addressing this problem by bringing the power of technology to the industry in a way in which it has not been applied to date. We are delighted to partner with Clarify on this effort to enable a more effective, efficient, and simply better health care experience for both physicians and the patients who need it.”

Clarify delivers precise care guidance through its three primary solutions:

Clarify Care Prism

Clarify’s machine-learning analytics solution provides case-mix adjusted insights on performance in value-based payment programs and beyond. The solution unlocks granular clinical and operational variation insights on performance at the facility, physician, and/or patient levels with compelling, easily understandable visuals that empower change. Clarify recently became a Qualified Entity (QE), gaining access to the full Medicare data set for parts A, B, and D, through the Centers for Medicare and Medicaid Services (CMS).

“The Clarify Care Journey Platform is built upon an ever-growing data set that represents one third of the U.S. population and over 20% of our nation’s health care spend,” said Todd Gottula, President, CTO and Co-Founder, Clarify Health Solutions. “We are giving customers a rare insight into the precise drivers of cost, quality, and outcomes, at the patient level, completely revolutionizing how care journeys are mapped and directed by clinicians.”

Clarify Care Pilot

Clarify’s real-time patient engagement solution effectively guides the patient through his or her care journey. A doctor or health care professional prescribes a personalized “care map” directly to the patient via the mobile or browser-based app. Care Pilot is designed to engage the patient outside of the clinic by providing critical information about care regimens, collecting self-reported data, and enabling communication with care teams through real-time patient monitoring.

Clarify Care Connect

Clarify’s real-time care navigation solution empowers clinicians to monitor and guide patients efficiently through their journey of care in real time. Granular patient stratification and journey assignment at the beginning of a journey creates a workstation for the efficient management of a panel of patients. Ongoing assessment of patient risk levels, prioritized alerts to focus on patients requiring intervention, and critical patient-level information are all easily accessible by the care team.

About Clarify Health Solutions

Our vision is to power better care by personalizing and optimizing every care journey. Clarify delivers the insights and digital solutions that empower physicians, health systems, and payers to optimize care and thrive in a value-based world. The Clarify platform seamlessly integrates powerful analytics, artificial intelligence, real-time patient navigation, and smart workflows to guide patients and their caregivers proactively through personalized care journeys. Clarify brings committed and passionate colleagues with backgrounds in big data and AI engineering from financial services together with extensive clinical operations expertise. The team has a track record of achieving over $1 billion in improvement at more than 125 health systems, payers, and pharmaceutical companies and deploying cloud-based software at over 5,000 institutions. For more information, please visit http://www.clarifyhealth.com.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate and credit, with strategic manager partnerships that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

 

Clarify Health Solutions
Kendall Reischl, 408-768-3176
kendall@clarifyhealth.com
KKR
Kristi Huller or Cara Major, 212-750-8300
media@kkr.com

Source: Clarify Health Solutions, Inc

 

 

News Provided by Acquire Media


Download PDF

Back to Press Releases

Media Contacts

Americas

Kristi Huller
Julia Kosygina
Liidia Liuksila
Telephone: +1 (212) 750-8300

Email: media@kkr.com

EMEA

Annabel Arthur
Miles Radcliffe-Trenner
Julia Leeger
Telephone: +44 20 7839 9800

Email: kkrpr-uk@kkr.com

Asia-Pacific

Wei Jun Ong
Telephone: +852 3602 7335

Email: media@kkr.com

Investor Relations

‍Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com

×

Listen to webcast

This presentation contains certain forward-looking statements pertaining to KKR & Co. Inc. and its consolidated subsidiaries (collectively “KKR”), including certain investment funds, vehicles and accounts that are managed by KKR (each, a “fund”). Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. The forward-looking statements are based on KKR’s beliefs, assumptions and expectations of its future performance, taking into account all information currently available to it. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to KKR or are within its control. If a change occurs, KKR’s business, financial condition, liquidity and results of operations, including but not limited to, assets under management, fee paying assets under management, after-tax distributable earnings, capital invested, syndicated capital, uncalled commitments, cash and short-term investments, fee related earnings, fee and yield segment EBITDA, core interest expense and book value, may vary materially from those expressed in the forward-looking statements. The following factors, among others, could cause actual results to vary from the forward-looking statements: whether KKR realizes all or any of the anticipated benefits from converting to a corporation and the timing of realizing such benefits; whether there are increased or unforeseen costs associated with the conversion, including any adverse change in tax law; the volatility of the capital markets; the general volatility of the capital markets; failure to realize the benefits of or changes in KKR’s business strategies including the ability to realize the anticipated synergies from acquisitions or strategic partnerships or other transactions; availability, terms and deployment of capital; availability of qualified personnel and expense of recruiting and retaining such personnel; changes in the asset management industry, interest rates or the general economy; underperformance of KKR's investments and decreased ability to raise funds; and the degree and nature of KKR’s competition. All forward-looking statements speak only as of the date they are made. KKR does not undertake any obligation to update any forward-looking statements to reflect circumstances or events that occur after the date on which such statements were made except as required by law. In addition, KKR’s business strategy is focused on the long-term and financial results are subject to significant volatility.

Additional information about factors affecting KKR, including a description of risks that may be important to a decision to purchase or sell any common or preferred stock of KKR & Co. Inc., can be found in KKR & Co. Inc.’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other filings with the SEC, which are available at www.sec.gov.

I understand  |   Go back
×

Listen to Presentation

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not intended to be a solicitation or sale of any of the securities, funds or services that it may discuss. Please click on "I understand" to view the presentation.

I understand  |   Go back